RZLT
Rezolute Inc
NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY
$3.20
+2.56% today
Updated 2026-04-30
Market cap
$293.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$1 – $11
Volume
2.4M
Rezolute Inc (RZLT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-74.00%
ROA
-44.10%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-49287.00 | — | — | — |
| 2013 | — | $-6.73M | — | — | — |
| 2014 | $0.00 | $-9.73M | — | — | — |
| 2015 | $0.00 | $-11.36M | — | — | — |
| 2016 | $0.00 | $-14.94M | — | — | — |
| 2017 | $0.00 | $-20.28M | — | — | — |
| 2018 | $0.00 | $-29.86M | — | — | — |
| 2019 | $0.00 | $-30.42M | — | — | — |
| 2020 | $0.00 | $-20.33M | — | — | — |
| 2021 | $0.00 | $-20.90M | — | — | — |
| 2022 | $0.00 | $-41.06M | — | — | — |
| 2023 | $0.00 | $-51.79M | — | — | — |
| 2024 | $0.00 | $-68.46M | — | — | — |
| 2025 | $0.00 | $-74.41M | — | — | — |